GlaxoSmithKline Pharmaceuticals Limited — Others, 26-06-2025: Trading Window

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting to approve the financial results for the quarter and half-year ended June 30, 2025. The company has also closed its trading window from July 1 to August 5, 2025, during which its shares cannot be bought or sold. This trading halt aligns with the announcement of its upcoming quarterly financial results, signaling a period of sensitive information management to protect shareholder interests.